Department of Mental Health, Center for Eating Disorders, Sacco Hospital, Milan, Italy.
Int Clin Psychopharmacol. 2009 Nov;24(6):312-7. doi: 10.1097/YIC.0b013e32832ac828.
Treatment for binge-eating disorder (BED) is directed towards either the physical or psychopathological impairments, and often does not cover all the alterations characterizing the disease. In 30 BED patients, we monitored the effects of three types of 6-month treatment, randomly assigned to one of the three treatment groups, each consisting of 10 patients. Group 1 received a 1700-kcal diet (21% proteins, 27% lipids, 52% carbohydrate), cognitive-behavioural therapy (CBT), sertraline (50-150 mg/day) and topiramate (25-150 mg/day); group 2 received the same diet, CBT, sertraline; and group 3 received nutritional counselling and CBT. Binge frequency and weight were assessed every month. The Eating Disorder Inventory-2, the Symptoms Check List-90-Revised (SCL-90-R) and the Personality Diagnostic Questionnaire-4-Revised (PDQ-4-R) were administered before and after treatment. Binge frequency and excessive weight decreased significantly only in group 1 patients, in whom improvement was noted in total Eating Disorder Inventory-2 scores and the subitems 'bulimia', 'drive for thinness', 'maturity fear', 'ascetism', in total SCL-90-R scores and in the subitem 'somatization', in PDQ-4-R subitems 'schizotypic personality' and 'dependent personality'. Group 2 patients improved on the SCL-90-R subitems 'depression' and 'interpersonal relationship' and in the PDQ-4-R 'schizoid personality'. Combination therapy seems to be the only fully effective treatment in BED patients.
治疗暴食障碍(BED)的方法针对的是生理或心理病理损伤,而且通常不能涵盖疾病的所有特征改变。在 30 名暴食障碍患者中,我们监测了三种为期 6 个月的治疗方法的效果,将患者随机分配到三个治疗组中的任意一组,每组 10 名患者。第一组接受 1700 卡饮食(21%蛋白质、27%脂肪、52%碳水化合物)、认知行为疗法(CBT)、舍曲林(50-150mg/天)和托吡酯(25-150mg/天);第二组接受相同的饮食、CBT 和舍曲林;第三组接受营养咨询和 CBT。每月评估一次暴食频率和体重。治疗前后分别进行饮食障碍问卷-2(Eating Disorder Inventory-2)、症状检查表-90 修订版(Symptoms Check List-90-Revised,SCL-90-R)和人格诊断问卷-4 修订版(Personality Diagnostic Questionnaire-4-Revised,PDQ-4-R)。仅第一组患者的暴食频率和超重显著下降,且患者的总饮食障碍问卷-2 评分和“贪食”、“对苗条的追求”、“对成熟的恐惧”、“禁欲主义”、总 SCL-90-R 评分和“躯体化”以及 PDQ-4-R 子项“分裂型人格”和“依赖型人格”均有所改善。第二组患者在 SCL-90-R 的“抑郁”和“人际关系”以及 PDQ-4-R 的“分裂样人格”子项上有所改善。联合疗法似乎是暴食障碍患者唯一完全有效的治疗方法。